InterventionsHumans

Rates of Atrial Fibrillation and Atrial Flutter in Non-diabetic Obese Adult Patients on Tirzepatide

AHA Scientific Sessions 2025 Abstract

The paper

Tusharbhai Patel, Justin Haloot, Irakli Giorgberidzė, Hamid Afshar

Baylor College of Medicine

AHA Scientific Sessions 2025 Abstract · 3 Nov 2025

Presented at AHA Scientific Sessions 2025 · Abstract 4366880

doi.org/10.1161/circ.152.suppl_3.4366880

GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026